1. Home
  2. TSHA vs BNED Comparison

TSHA vs BNED Comparison

Compare TSHA & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • BNED
  • Stock Information
  • Founded
  • TSHA 2019
  • BNED 1965
  • Country
  • TSHA United States
  • BNED United States
  • Employees
  • TSHA N/A
  • BNED N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • BNED Other Specialty Stores
  • Sector
  • TSHA Health Care
  • BNED Consumer Discretionary
  • Exchange
  • TSHA Nasdaq
  • BNED Nasdaq
  • Market Cap
  • TSHA 262.4M
  • BNED 311.3M
  • IPO Year
  • TSHA 2020
  • BNED N/A
  • Fundamental
  • Price
  • TSHA $1.24
  • BNED $9.33
  • Analyst Decision
  • TSHA Strong Buy
  • BNED Hold
  • Analyst Count
  • TSHA 8
  • BNED 1
  • Target Price
  • TSHA $6.63
  • BNED N/A
  • AVG Volume (30 Days)
  • TSHA 2.4M
  • BNED 336.1K
  • Earning Date
  • TSHA 05-13-2025
  • BNED 03-10-2025
  • Dividend Yield
  • TSHA N/A
  • BNED N/A
  • EPS Growth
  • TSHA N/A
  • BNED N/A
  • EPS
  • TSHA N/A
  • BNED N/A
  • Revenue
  • TSHA $8,333,000.00
  • BNED $1,567,800,000.00
  • Revenue This Year
  • TSHA N/A
  • BNED $2.74
  • Revenue Next Year
  • TSHA N/A
  • BNED N/A
  • P/E Ratio
  • TSHA N/A
  • BNED N/A
  • Revenue Growth
  • TSHA N/A
  • BNED N/A
  • 52 Week Low
  • TSHA $1.05
  • BNED $6.05
  • 52 Week High
  • TSHA $4.32
  • BNED $135.00
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 40.35
  • BNED 48.32
  • Support Level
  • TSHA $1.05
  • BNED $8.38
  • Resistance Level
  • TSHA $1.36
  • BNED $9.58
  • Average True Range (ATR)
  • TSHA 0.17
  • BNED 0.66
  • MACD
  • TSHA -0.01
  • BNED 0.00
  • Stochastic Oscillator
  • TSHA 25.68
  • BNED 48.15

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: